Consistency: Strong agreement. Notes, review and PN node all describe the prototypical TIM23/PAM J-protein that stimulates matrix HSP70 (mortalin/HSPA9). Experimentally established for the human protein (PMID:20053669: ~70% ATPase stimulation in the Magmas:DnaJC19 complex; PMID:19564938). No contradictions. This is the best-supported member of the six (vs DNAJC15's PAM18-orthologue role; correctly distinguished as the genuine TIM23-associated import J-protein).
PN story / NEW pressure: PN proposes GO:0030544 Hsp70 protein binding (verified real). The binding is genuine (DNAJC19 directly engages/stimulates mortalin), but the review already records the stronger, more informative GO:0001671 ATPase activator activity (experimentally supported). GO:0030544 is NOT a parent of GO:0001671 — it is the binding axis, broader/less informative than the existing activator-activity annotation. Not an ADD; the function is already captured better.
Mapping strategy: No node change warranted. As with DNAJC15, "more_specific_than_existing_goa" is inaccurate — GO:0030544 is not more specific than the existing GO:0001671 ATPase activator activity. The secondary cardiolipin/prohibitin role (ISS, GO:1900208) sits outside this node and is correctly non-core in the review.
Evidence alignment: Excellent overlap on the import-motor biology. Review anchors on PMID:20053669 and PMID:19564938 (both VERIFIED) plus the DCMA disease paper PMID:16055927 (UNVERIFIED, uncached). PN reference titles align with the J-domain/Hsp70-stimulation framing.
Verdict: Consistent and well-supported; PN's Hsp70-binding projection is true but already captured more informatively (ATPase activator activity). No edits required.